US Material Events SEC 8-K Filings — April 23, 2026

23-04-2026

IQVIA Holdings Inc. held its 2026 Annual Meeting of Stockholders on April 23, 2026, electing all nine director nominees by majority vote, with support ranging from approximately 92% for Ari Bousbib to 99% for William G. Kaelin Jr., M.D. Stockholders approved the 2026 Incentive and Stock Award Plan by a vote of 96,987,612 for versus 51,006,455 against, ratified PricewaterhouseCoopers LLP as auditor overwhelmingly, and approved 2025 named executive officer compensation on an advisory basis (118,398,355 for versus 29,398,856 against). However, a stockholder proposal for separate Chairman and CEO roles failed decisively (36,717,802 for versus 111,154,252 against).

• ·Proposal No. 1 Director votes - Ari Bousbib: 138,448,357 For, 8,565,570 Against, 1,214,049 Abstain; Carol J. Burt: 135,795,078 For, 12,212,098 Against, 220,801 Abstain; John G. Danhakl: 142,605,129 For, 5,318,909 Against, 303,939 Abstain; James A. Fasano: 141,704,011 For, 6,303,043 Against, 220,922 Abstain; Colleen A. Goggins: 139,720,846 For, 8,288,024 Against, 219,107 Abstain; William G. Kaelin Jr., M.D.: 147,942,854 For, 64,869 Against, 220,254 Abstain; John. M. Leonard, M.D.: 143,748,610 For, 4,258,365 Against, 221,001 Abstain; Leslie Wims Morris: 147,058,789 For, 867,756 Against, 301,430 Abstain; Sheila A. Stamps: 147,357,181 For, 650,699 Against, 220,095 Abstain
• ·Proposal No. 2 NEO compensation: 118,398,355 For, 29,398,856 Against, 430,765 Abstain
• ·Proposal No. 3 Auditor ratification: 140,865,227 For, 14,140,721 Against, 212,076 Abstain
• ·Proposal No. 4 2026 Plan: 96,987,612 For, 51,006,455 Against, 233,909 Abstain
• ·Proposal No. 5 Separate Chairman/CEO: 36,717,802 For, 111,154,252 Against, 355,920 Abstain
• ·2026 Plan authorizes performance metrics including revenue, adjusted EBITDA, earnings per share, adjusted diluted earnings per share, cash flow, free cash flow as % of adjusted net income, relative total stockholder return

23-04-2026

SES AI Corp reported Q1 2026 revenue of $6.7 million, up 47% QoQ from Q4 2025 ($4.6 million implied) and 16% YoY from Q1 2025 ($5.8 million), driven by ESS via UZ Energy, drone samples, and Molecular Universe subscriptions, while reaffirming FY2026 revenue guidance of $30-35 million and announcing a $20 million multiyear contract with ATG EPower. Gross margin improved to 18.1% QoQ from 11.3% but declined sharply YoY from 78.7% due to revenue mix shift to lower-margin products; operating expenses fell to $19.1 million YoY from $27.8 million but net loss held steady at $12.1 million similar to Q1 2025. The company also announced CFO Jing Nealis transitioning out effective April 27, 2026, with Yi (Ray) Liu appointed as successor.

• ·Q1 2026 GAAP net loss per share: $(0.04), unchanged YoY
• ·Adjusted EBITDA loss: $12.8M in Q1 2026 vs $13.8M in Q4 2025 (improvement) and $16.5M in Q1 2025
• ·Expected FY2026 blended gross margin: approximately 15%
• ·Routine S-3 shelf registration to be filed with 10-Q as current expires April 28, 2026
• ·Total assets: $253.5M as of March 31, 2026 vs $272.6M as of Dec 31, 2025

23-04-2026

Jefferson Capital Systems, LLC (JCap) and affiliates (CL Holdings, LLC, JC International Acquisition, LLC, and CFG Canada Funding, LLC) entered into Amendment No. 8 to their Credit Agreement, increasing the maximum Aggregate Commitment to $1,425,000,000 and establishing a $150,000,000 Incremental Commitment from new Incremental Lenders. Citizens Bank, N.A. serves as Administrative Agent, with Bank of Montreal and Deutsche Bank Securities Inc. as joint lead arrangers. The amendment updates sanctions-related definitions and compliance representations, effective upon satisfaction of specified conditions including no Default.

• ·Original Credit Agreement dated May 21, 2021, with prior amendments on December 28, 2021; February 28, 2022; April 26, 2023; September 29, 2023; June 3, 2024; November 13, 2024; and October 27, 2025.
• ·Amendment effective upon receipt of executed counterparts, secretary's certificates, good standing certificates, KYC documentation, solvency certificate, fees, and confirmation of no Default.
• ·Updated definitions for 'Sanctioned Country', 'Sanctioned Person', and 'Sanctions' to include additional jurisdictions like EEA Member Countries and Government of Canada.

23-04-2026

GCI Holdings, LLC, a wholly owned subsidiary of GCI Liberty, Inc. (Nasdaq: GLIBA, GLIBK), announced a definitive agreement to acquire 100% of Quintillion (Q Gateway Intermediate Holdings, LLC) for a $310 million enterprise value, subject to adjustments, including reimbursement of up to $50 million in qualifying capital expenditures for the Nome-to-Homer Express project and a $160 million unsecured loan provided shortly after signing. The deal combines Quintillion’s 1,800+ miles of existing fiber and ~1,500 miles of planned expansion with GCI’s statewide network to enhance reliability, resiliency, and performance in Alaska’s challenging environments. No financial performance declines or flat metrics are reported; the acquisition supports strategic goals like national defense and broadband expansion without noted disruptions to existing services.

• ·Closing anticipated following regulatory approval and customary conditions.
• ·Additional consideration payable in 2028, 2029, and 2031 via post-closing earnout based on financial metrics.
• ·Quintillion operates primarily on wholesale basis, supporting carriers, healthcare, education, and public safety.
• ·Press release dated April 22, 2026; SEC 8-K filed April 23, 2026.

23-04-2026

Brand Engagement Network Inc. entered into a Securities Purchase Agreement with Ben Capital Fund I, LLC on April 21, 2026, for a private placement of 25,492 shares of common stock at $39.25 per share (120% of the April 21 closing price), yielding gross proceeds of $1,000,561 with 100% warrant coverage; the first installment of $250,101 closed immediately, and the remaining $750,460 is expected before May 29, 2026. Additionally, the Company received $1,114,164 in cash from warrant exercises during April. No declines or flat metrics were reported.

• ·Securities offered and sold pursuant to exemptions from registration requirements of the Securities Act of 1933.
• ·Company qualifies as an emerging growth company.

23-04-2026

Nektar Therapeutics announced the pricing of an upsized $325 million public offering of 3,532,609 shares of common stock at $92.00 per share, with gross proceeds expected to be approximately $325 million before expenses. The company granted underwriters a 30-day option to purchase up to an additional 529,891 shares. Net proceeds will fund general corporate purposes, including research and development, clinical development such as Phase 3 trials for rezpegaldesleukin in atopic dermatitis and alopecia areata, and manufacturing.

• ·Offering expected to close on April 23, 2026, subject to customary conditions.
• ·Underwriters: Jefferies, TD Cowen, and Piper Sandler as joint bookrunning managers; Citigroup as bookrunner.
• ·Pursuant to shelf registration statement on Form S-3ASR (No. 333-291466) filed November 12, 2025.

23-04-2026

Indaptus Therapeutics, Inc. appointed Tim Ruan and Dr. Yi Zhang as independent Class II directors effective April 22, 2026, with Mr. Ruan joining the Audit Committee as a financial expert and Dr. Zhang joining the Nominating Committee. Both bring extensive experience in finance/biotech (Ruan from Ocumension Therapeutics, Goldman Sachs, Morgan Stanley) and IP/life sciences (Zhang from JunHe). On the same day, director Matthew McMurdo resigned with no disagreements on company matters.

• ·Appointments decided on April 17, 2026; Director Agreements and Indemnification Agreements executed effective April 22, 2026 (Exhibits 10.1 and 10.2).
• ·Mr. Ruan qualifies as an 'audit committee financial expert' per Item 407(d)(5)(ii) of Regulation S-K.
• ·No arrangements, family relationships, or material interests under Item 404(a) of Regulation S-K for new directors.
• ·Junyi Dai and Qinglai Lu serve as Class III directors (appointed March 18 and April 8, 2026, terms to 2027 annual meeting).

23-04-2026

On April 17, 2026, Idaho Copper Corporation closed a private offering of $1,357,947 in principal amount of convertible promissory notes due in 12 months at an initial conversion price of $6.00 per share, along with warrants to purchase 226,332 shares at $7.50 per share exercisable for 5 years. Of the total, $102,947 in existing notes were converted on a dollar-for-dollar basis by two investors. ThinkEquity LLC served as exclusive placement agent, receiving fees and warrants for 10% of the shares issuable upon note conversion.

• ·Issuance exempt under Section 4(a)(2) and Rule 506(b) of Regulation D to accredited investors only.
• ·Notes bear no interest unless default, then 18% per annum.
• ·Automatic conversion upon national exchange listing at lower of 70% of offering price or $6.00.
• ·Forms filed as Exhibits: 4.1 (Warrant), 10.1 (Subscription Agreement), 10.2 (Note).

23-04-2026

Texas Capital Bancshares reported first quarter 2026 net income available to common stockholders of $69.5 million ($1.56 per diluted share), up 63% YoY from $42.7 million but down 28% QoQ from $96.3 million ($2.12 per share), amid higher provisions for credit losses ($16.0 million) and net charge-offs ($17.4 million). The company initiated its first quarterly common stock cash dividend of $0.20 per share and highlighted revenue diversification with non-interest income up 42% YoY to $69.3 million, though net interest income fell 5% QoQ to $254.7 million and efficiency ratio worsened to 65.9%. Capital remains strong with CET1 at 12.0%, total assets grew to $33.5 billion, and book value per share rose 11% YoY to $75.71.

• ·Criticized loans $650.6 million at March 31, 2026, up from $634.9 million at Dec 31, 2025 but down from $762.9 million at March 31, 2025.
• ·Non-accrual LHI $144.9 million (0.58% of total LHI) at March 31, 2026, up from $116.9 million (0.49%) QoQ and $93.6 million (0.42%) YoY.
• ·Allowance for credit losses to total LHI 1.32% at March 31, 2026, down from 1.38% QoQ and 1.48% YoY.
• ·Common stock repurchased at weighted average $96.82 per share.
• ·Preferred dividend $14.375 per share Series B, payable June 15, 2026.

23-04-2026

On April 19, 2026, SBC Medical Group Holdings Incorporated entered into an underwriting agreement with Maxim Group LLC for the sale of 3,100,000 shares of its common stock by Dr. Yoshiyuki Aikawa, the CEO and Chairman as selling stockholder; the underwriters received a 45-day option for up to 465,000 additional shares. The offering closed on April 21, 2026, with no shares sold by the Company and no proceeds received by it. This secondary offering was conducted pursuant to a Form S-3 registration statement filed on December 29, 2025.

• ·Underwriting Agreement filed as Exhibit 1.1
• ·Pursuant to Registration Statement on Form S-3 (File No. 333-292451), filed December 29, 2025
• ·Company is an emerging growth company

23-04-2026

Goldman Sachs Private Credit Corp., acting as equityholder and investment advisor, along with borrower GS Private Credit SPV Public I LLC, entered into the Fourth Amendment to the Revolving Credit and Security Agreement on April 17, 2026, with BNP Paribas as administrative agent and lender, and State Street Bank and Trust Company as collateral agent. The amendment modifies the facility originally dated September 28, 2023, following prior amendments on May 30, 2024, October 31, 2024, and January 31, 2025, with changes detailed in Appendix A (not provided). The parties represent no Default or Event of Default exists, and all prior representations and warranties remain true and correct.

• ·Amendment effective upon execution, payment of fees, consents/approvals, and receipt of legal opinion from Dechert LLP.
• ·Governed by New York law.

23-04-2026

Teledyne Technologies Incorporated filed a Restated Certificate of Incorporation on April 23, 2026, restating and amending its original certificate filed on August 23, 1999. The document authorizes 125,000,000 shares of Common Stock and 15,000,000 shares of Preferred Stock, both with a par value of $0.01 per share, and outlines governance provisions including board management authority, indemnification rights, and restrictions on stockholder actions to meetings only. No financial performance metrics or period-over-period changes are reported.

• ·Registered office: 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
• ·Stockholder actions required at meetings; no written consents permitted.
• ·Special meetings callable by Board, Chairman, CEO, or Secretary upon 25% stockholder demand.
• ·Director liability limited except for duty of loyalty breaches, bad faith, etc.

23-04-2026

Coeur Mining, Inc. announced the final results of its exchange offer and consent solicitation for New Gold Inc.'s US$400,000,000 6.875% Senior Notes due 2032, with US$385,800,000 aggregate principal amount (96.45% of outstanding) validly tendered and accepted in exchange for US$385,774,000 in new Coeur 6.875% Senior Notes due 2032 and approximately US$771,600 in cash. The exchange supports integration of New Gold into Coeur's operations, including mines like New Afton, Rainy River, and others. No significant declines noted, with high tender participation indicating strong holder support.

• ·Early Participation Date: April 3, 2026 (5:00 p.m. New York City time)
• ·Expiration Date: April 20, 2026 (5:00 p.m. New York City time)
• ·Settlement Date: April 22, 2026
• ·Exchange Offer Memorandum dated March 23, 2026
• ·Remaining untendered Existing Notes: US$14,200,000 (3.55%)

23-04-2026

On April 21, 2026, the Board of Directors of Capstone Green Energy Holdings, Inc. approved an amendment to the 2023 Equity Incentive Plan, increasing the maximum number of shares of common stock issuable from 4,000,000 to 7,000,000. This change expands the equity pool available for incentives but introduces potential shareholder dilution. The amendment is filed as Exhibit 10.1.

• ·Form 8-K filed on April 23, 2026; event reported as of April 21, 2026; signed April 22, 2026
• ·Common stock trades as CGEH on OTCQX, par value $0.001 per share

23-04-2026

BridgeBio Oncology Therapeutics, Inc. (BBOT) announced the appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman, effective April 20, 2026. Former CEO Eli Wallace, PhD, will transition to Senior Adviser. The changes are positioned to support BBOT's clinical-stage assets entering Phase 1b expansions and combinations in RAS and PI3Kα malignancies.

• ·Announcement date: April 22, 2026
• ·Filing date: April 23, 2026
• ·Dr. Beltran joined BridgeBio Pharma in 2020, became CSO of BBOT in July 2023; prior roles at UNITY Biotechnology and Amgen
• ·BBOT focused on RAS-pathway malignancies with three clinical assets advancing to Phase 1b expansions

23-04-2026

Arvana, Inc. entered into a Settlement Agreement on January 13, 2026, with J.P. Carey Enterprises, Inc. to resolve claims totaling $188,379.32 through the issuance of an undetermined number of common stock shares at a 40% discount, plus an additional 250,000 shares for legal fees, approved by court order on April 11, 2026. While this resolves ongoing litigation without cash outlay, it poses significant shareholder dilution risk as the variable share issuance could exceed current outstanding shares and is subject to a 4.99% beneficial ownership limit, requiring multiple tranches.

• ·Settlement Agreement dated January 13, 2026; Court fairness hearing on April 7, 2026; Order entered April 11, 2026.
• ·Litigation: J.P. Carey Enterprises, Inc. v. Arvana, Inc., Case No. CACE-26-000427, Circuit Court of the Seventeenth Judicial Circuit, Broward County, Florida.
• ·Shares issued under Section 3(a)(10) exemption; Company must maintain sufficient authorized shares and avoid impairing stock trading status.

23-04-2026

Axos Bank, a subsidiary of Axos Financial, Inc., entered into a Purchase and Assumption Agreement with Capital One, National Association on April 22, 2026, to acquire the IRA custodial business, including traditional and Roth IRA accounts (excluding Closed Accounts and Excluded Accounts), related Acquired Assets, and Assumed Liabilities such as Deposits in CD and Savings Accounts. The transaction includes a Deposit Premium Amount (redacted) based on aggregate Deposit balances as of Closing and requires Regulatory Approvals, including from the OCC under the Bank Merger Act. No specific quantitative portfolio sizes or values were disclosed.

• ·Cut-Off Date: seven (7) days prior to Closing Date
• ·Opt-Out Date: specified in Transfer Communication for account holder objections
• ·Closing effective at 12:01 a.m. Eastern time on Closing Date
• ·Knowledge defined by specific individuals for Seller (Rich Finn, David Roberts) and Purchaser (Greg Garrabrants, Derrick Walsh, Johnny Lai)

23-04-2026

Nomadar Corp. (NASDAQ: NOMA) appointed former NBA star José Manuel Calderón to its Board of Directors effective April 23, 2026, to advance its global sports, technology, infrastructure, and capital markets strategy, particularly supporting the JP Financial Arena project in southern Spain. The move follows recent milestones including securing approximately $7.3 million in new capital and a binding agreement to purchase 130,000 square meters of land for the arena. Calderón's experience strengthens governance and institutional positioning amid Nomadar's expansion in Europe.

• ·Nomadar is a subsidiary of Cádiz CF, a 115-year-old La Liga soccer club.
• ·Calderón serves on the board of another Nasdaq-listed company.

23-04-2026

Cass Information Systems reported Q1 2026 net income of $8.8 million and diluted EPS of $0.67, with adjusted EPS rising 26.9% YoY to $0.66 amid net interest margin expansion to 3.95% from 3.75% and facility dollar volumes up 7.4% YoY. However, processing fees declined 4.5% YoY due to lower transportation (-3.1%) and facility (-4.4%) invoice volumes, while personnel expenses remained flat. Management highlighted ongoing efficiency initiatives, strong asset quality with non-performing loans down 55.1%, and a quarterly dividend of $0.32 per share.

• ·Repurchased 64,802 shares at weighted average price of $44.34.
• ·Quarterly dividend of $0.32 per share payable June 15, 2026 to shareholders of record June 5, 2026.
• ·No loan charge-offs; allowance for credit losses to loans ratio of 1.27%.
• ·Non-performing loans totaled $3.1 million at March 31, 2026.
• ·Expects loan growth of 6-8% for full year 2026.

23-04-2026

Synera Studio Inc entered into a Software Development Agreement with LUMARK HK LIMITED on April 20, 2026, for the design, development, and delivery of a custom software video editor application for Windows, commencing April 16, 2026, for a 22-week term. The total contract price is $70,380, payable as a $30,000 advance upon execution and $40,380 upon completion and acceptance. The agreement includes provisions for IP transfer post-acceptance, termination for convenience by the Company without further payment obligations, and a liability cap equal to total payments made.

• ·Agreement filed as Exhibit 10.1
• ·Company is an emerging growth company
• ·Principal executive offices: Kamenicka Street 7, Topola, Serbia 34310
• ·Governing law, confidentiality, indemnification, and warranties included
• ·Liability limited to total amount paid by Company

23-04-2026

The 8-K filing discloses the Pooling and Servicing Agreement (PSA) dated and effective as of April 1, 2026, for Commercial Mortgage Pass-Through Certificates, Series 2026-C66, establishing the trust structure for a commercial mortgage-backed securities issuance. Key parties include Wells Fargo Commercial Mortgage Securities, Inc. as Depositor, Trimont LLC as Master Servicer, LNR Partners, LLC as Special Servicer, Computershare Trust Company, National Association as Certificate Administrator, Deutsche Bank National Trust Company as Trustee, and Belloak, LLC as Operating Advisor and Asset Representations Reviewer. No financial performance metrics, period comparisons, or quantitative data are provided in the filing.

• ·Filing Type: 8-K, Items: 1.01, 9.01, dated April 23, 2026
• ·Subcategory: Material Agreement Entry
• ·Includes exhibits such as Mortgage Loan Schedule (Exhibit B), Class A-SB Planned Principal Balance Schedule (Schedule 2), and various certification forms

23-04-2026

Semnur Pharmaceuticals, Inc. terminated two material securities purchase agreements on April 20, 2026, without issuing any shares under either: the deSPAC PIPE SPA with JW Capital Securities Limited for 1,250,000 shares at $16.00 per share (potential $20M proceeds) and the Semnur/Biconomy SPA with Biconomy PTE. Ltd. for 6,250,000 shares at $16.00 per share payable in Bitcoin (potential $100M proceeds). These agreements were entered into in August and September 2025 in connection with the September 22, 2025 Business Combination.

• ·deSPAC PIPE SPA originally dated August 20, 2025; closing extended but never occurred.
• ·Semnur/Biconomy SPA dated September 23, 2025.
• ·Terminations effective April 20, 2026, pursuant to Section 8 of each SPA.
• ·Company headquartered at 960 San Antonio Road, Palo Alto, California, 94303.

23-04-2026

MaxLinear reported Q1 2026 net revenue of $137.2 million, up 1% sequentially from Q4 2025 and 43% YoY from Q1 2025, driven by infrastructure segment growth of 136% YoY from optical data center products. However, GAAP gross margin dipped slightly to 57.5% from 57.6% sequentially, operating expenses rose to $96.1 million (up ~3% seq), resulting in GAAP operating loss of 13% of revenue (worsening from 11% prior quarter) and diluted loss per share of $0.52 (vs $0.17 prior quarter). Non-GAAP operating income remained flat at 16% of revenue with EPS of $0.22 (up from $0.19), and the company amended its credit agreement to extend maturity to March 2028 and increase the facility by $30 million to $130 million available.

• ·Q2 2026 net revenue outlook: $160 million to $170 million
• ·Q2 GAAP gross margin outlook: 56.0% to 59.0%; non-GAAP: 58.0% to 61.0%
• ·Conference call: April 23, 2026 at 1:30 p.m. PT; replay available until May 7, 2026

23-04-2026

Venture Global Calcasieu Pass, LLC (VGCP), a subsidiary of Venture Global, Inc. (NYSE: VG), closed a $750,000,000 offering of 6.000% senior secured notes due 2036. Net proceeds, combined with cash on hand and hedge termination proceeds, were used to fully prepay VGCP's outstanding term loans and cover offering-related fees and expenses. The notes are guaranteed by affiliate TransCameron Pipeline, LLC and secured on a pari passu basis by first-priority interests in assets securing VGCP's existing credit facilities and notes.

• ·Notes mature on May 1, 2036
• ·Notes not registered under the Securities Act of 1933 and may not be offered or sold absent registration or exemption
• ·Venture Global's projects include Calcasieu Pass, Plaquemines LNG, and CP2 LNG in Louisiana
• ·Investor contact: IR@ventureglobalLNG.com; Media contact: press@ventureglobalLNG.com

23-04-2026

U.S. GoldMining Inc. entered into an Amendment Agreement dated April 23, 2026, with Continental Stock Transfer & Trust Company, amending Section 7(a) of the original Warrant Agency Agreement dated March 9, 2023. The key change grants the Company sole discretion to extend the Termination Date of Warrants issued in connection with its IPO of 2,000,000 units, each consisting of one share of Common Stock and one Warrant. The amendment does not adversely affect Warrant holders in a material respect and maintains all other terms of the original agreement.

• ·Original Warrant Agency Agreement dated March 9, 2023.
• ·Effective registration statement on Form S-1 (File No. 333-269693).
• ·Amendment executed under Section 20(a) of the Agency Agreement, without requiring approval of Warrant holders.

23-04-2026

Charter Communications, Inc. held its 2026 Annual Meeting of Stockholders on April 21, 2026, where all 13 director nominees were elected with strong majorities (ranging from 95% to 99% For votes among votes cast). Stockholders approved an amendment to the 2019 Stock Incentive Plan increasing available shares by 16.0 million, ratified KPMG LLP as independent auditors (99% For), and approved named executive officer compensation on an advisory basis (76% For); however, a stockholder proposal for a political expenditures report was rejected (18% For). No other matters were voted on.

• ·118,382,741 shares of Class A common stock and 1 share of Class B common stock (15,511,283 votes) represented at the meeting.
• ·Plan amendment: 90,820,528 For, 37,522,506 Against, 66,927 Abstain.
• ·NEO compensation: 98,047,867 For, 30,289,182 Against, 72,912 Abstain.
• ·Auditor ratification: 131,975,231 For, 1,840,776 Against, 78,017 Abstain.
• ·Political expenditures proposal: 23,286,541 For, 104,891,888 Against, 231,532 Abstain.

23-04-2026

Meridian Bank announced the retirement of George Collier from its Board of Directors after 21 years of service as a founding board member and initial investor. Collier's financial expertise from his role as Executive Vice President, Chief Financial Officer, and Director at Streamlight, Inc. contributed to the bank's stability and growth. President and CEO Chris Annas praised Collier's lasting legacy and impact on the organization.

• ·Collier served as director since 2004
• ·Meridian Bank serves Pennsylvania, New Jersey, Delaware, Maryland, and Florida
• ·Contact: Christopher J. Annas, CAnnas@meridianbanker.com, 484.568.5001

23-04-2026

LiveOne, Inc. entered into a Shares Issuance Agreement on April 17, 2026, with Broadcast Music, LLC (BMI) and its subsidiary Slacker, Inc., agreeing to issue 1,000,000 shares of common stock at a deemed price of $7.50 per share as full payment for music royalty obligations through March 31, 2027. The agreement also extends the related License Agreements through December 31, 2027, with automatic yearly renewals thereafter, and BMI agreed to volume restrictions on share sales (max 5% of ADTV, min 3,500 shares per day). No cash proceeds will be received by the Company, representing a non-cash settlement of liabilities.

• ·Shares issued pursuant to effective S-3 Registration Statement (File No. 333-284916), prospectus supplement filed April 23, 2026.
• ·License Agreements originally dated November 20, 2024, amended April 17, 2026.
• ·Settlement of share issuance expected on or about April 24, 2026.
• ·Post-April 1, 2027 obligations payable in cash.

23-04-2026

Digital Turbine, Inc. amended its Financing Agreement on April 20, 2026, reducing the liquidity covenant requirement to $15,000,000 for the period from April 1, 2026, to December 31, 2026. The company also amended certain outstanding warrants to suspend registration rights for the resale of underlying common stock shares until October 1, 2026. These actions are detailed in Exhibits 10.2 and 4.2 of the filing.

• ·Financing Agreement originally dated August 29, 2025 (Exhibit 10.1)
• ·Warrants form incorporated from September 2, 2025 8-K (Exhibit 4.1)

23-04-2026

Datavault AI Inc. entered into a Subscription Agreement dated April 16, 2026, to acquire 8,163,265 shares of Vivasor, Inc.'s Series A Common Stock at $6.125 per share for an aggregate purchase price of $50 million, to be paid entirely in non-cash consideration via the issuance of 75,942,666 shares of the Company's common stock. On April 23, 2026, the Company filed a prospectus supplement to its effective shelf registration statement (File No. 333-294502) to register the Datavault shares issued in the transaction. No financial performance metrics or comparisons are provided in the filing.

• ·Subscription Agreement filed as Exhibit 10.1
• ·Opinion of counsel by Paul Hastings LLP filed as Exhibit 5.1
• ·Prospectus supplement filed April 23, 2026, to shelf registration originally filed March 20, 2026, and effective March 25, 2026 (File No. 333-294502)

23-04-2026

On April 17, 2026, Ana Hooker resigned from the Board of Directors of Exagen Inc., effective immediately, reducing the board size from eight (8) to seven (7) members. Her resignation was not due to any disagreement with the company's operations, policies, or practices; she served on the Audit Committee and as chair of the Nominating and Corporate Governance Committee. Following her departure, the board committees were updated with Paul Kim as Audit Committee chair and financial expert, and Frank Stokes as Compensation Committee chair.

• ·Exagen Inc. is incorporated in Delaware, Commission File Number 001-39049, IRS Employer ID 20-0434866, headquartered at 1261 Liberty Way, Vista, CA 92081.
• ·Common Stock trades as XGN on The Nasdaq Global Market, par value $0.001 per share.
• ·Filing signed by Jeffrey G. Black, CFO, on April 23, 2026.

23-04-2026

FS CREIT Finance BB-1 LLC entered into the Tenth Amendment to its Master Repurchase Agreement with Barclays Bank PLC on April 21, 2026, extending the Availability Period to February 21, 2029. The Seller represents and warrants no Material Adverse Effect, Margin Deficit, Default, or Event of Default is occurring, and all prior representations remain true. A Funding Fee is due on February 21, 2028, along with Purchaser's expenses.

• ·Amendment filed as 8-K on April 23, 2026 under Items 1.01, 2.03, 9.01
• ·Original Master Repurchase Agreement dated February 22, 2021, with multiple prior amendments up to Ninth on April 1, 2025
• ·Governed by New York law

23-04-2026

Horizon Space Acquisition I Corp. shareholders passed a special resolution on April 23, 2026, amending the company's memorandum and articles of association to extend the deadline for consummating a Business Combination to June 12, 2027, from prior dates of October 27, 2025, and April 27, 2026. If the deadline is not met, the company will cease operations, redeem public shares at a per-share price equal to the Trust Account balance (including interest earned, less taxes and up to $100,000 for dissolution expenses), and liquidate. This amendment modifies Articles 48.7 and 48.8(a) to reflect the new timeline.

• ·Deletes and replaces Article 48.7 in its entirety
• ·Amends Article 48.8(a) by updating redemption obligation reference to June 12, 2027
• ·Redemption calculated as aggregate Trust Account amount (including interest, less taxes) divided by outstanding public shares

23-04-2026

F&M Trust, a subsidiary of Franklin Financial Services Corp. (FRAF), announced the promotion of Chad Carroll to President and Chief Operating Officer, effective April 28, 2026, while he also joins the F&M Trust Board of Directors. Carroll, who joined in 2023 as Executive Vice President and Chief Operating Officer and was promoted to Senior Executive Vice President in January 2026, will oversee day-to-day operations and support strategic growth. The bank manages $2.2 billion in assets across 23 community-banking locations.

• ·F&M Trust headquartered in Chambersburg, Pa., with locations in Franklin, Cumberland, Dauphin, Fulton, and Huntingdon Counties in Pennsylvania, and Washington County, Maryland.
• ·Carroll based out of the bank's corporate headquarters in Chambersburg.

23-04-2026

Lifeward Ltd. announced that Jeannine Lynch's employment as Vice President of Strategy and Market Access will terminate effective May 3, 2026, pursuant to notice on April 20, 2026, treated as without cause under her Employment Agreement dated July 9, 2021. Ms. Lynch will receive severance and benefits in accordance with the agreement, details of which were disclosed in the company's Form 10-K filed March 18, 2026. No successor has been named.

• ·Termination notice provided on April 20, 2026.
• ·Form 8-K filed on April 23, 2026.

23-04-2026

Rising Dragon Acquisition Corp., a SPAC, issued a US$50,000 interest-free promissory note to SZG Limited on April 15, 2026, to fund an extension of time to complete its initial Business Combination under the Merger Agreement dated January 27, 2025. The note is payable upon Business Combination closing or convertible into private units at US$10.00 per unit, with proceeds required to be deposited into the trust account initially funded at US$57,787,500. No negative financial metrics are present, indicating progress toward the merger without immediate repayment pressure.

• ·Promissory note dated April 15, 2026; filing date April 23, 2026
• ·IPO Prospectus dated October 10, 2024
• ·Merger Agreement dated January 27, 2025
• ·Trust Agreement dated October 10, 2024
• ·Note terminates without payment if Merger Agreement terminated under specified conditions or Business Combination fails to close for reasons not attributable to Maker

23-04-2026

Patryk P. Goscianski resigned as Chief Financial Officer, principal financial and accounting officer, and Secretary of Burzynski Research Institute, Inc., effective April 17, 2026, with no disagreements on operations, policies, or practices. The Board appointed Stanislaw R. Burzynski, M.D., Ph.D., the Company's 83-year-old President, Chairman, and principal executive officer, as the new CFO, principal financial and accounting officer, and Secretary, effective the same date, with no additional compensation. Dr. Burzynski is the controlling stockholder and related to the other board members.

• ·Resignation letter dated April 16, 2026, filed as Exhibit 17.1.
• ·No related party transactions required to be disclosed under Item 404(a) of Regulation S-K other than the three referenced agreements.
• ·Biographical history of Dr. Burzynski and agreement descriptions incorporated by reference from Form 10-K for year ended February 28, 2025.
• ·Dr. Burzynski will serve as both principal executive officer and principal financial officer.

23-04-2026

Edison International (NYSE: EIX) and Southern California Edison elected M. Susan Hardwick as an independent director to both companies' boards, effective April 23, 2026. Hardwick, with over 35 years of experience including as former CEO of American Water Works Company, Inc., offers expertise in utility operations, finance, capital allocation, risk management, and regulatory affairs. Company leaders highlighted her alignment with priorities in safety, reliability, infrastructure planning, and clean energy delivery.

• ·Hardwick served as CEO of American Water Works from 2022 until retirement in May 2025.
• ·Previously held roles as president, executive vice president, and CFO at American Water; nearly two decades at Vectren in finance and leadership.
• ·Currently serves on boards of Core & Main, Inc., Tetra Tech, Inc., and New Jersey Resources Corporation.
• ·Holds bachelor’s degree from Indiana University and is a Certified Public Accountant (inactive).

23-04-2026

Paycom Software, Inc. (Holdings) and Paycom Payroll, LLC (Borrower) entered into an Amended and Restated Credit Agreement dated April 23, 2026, amending and restating the prior Credit Agreement from July 29, 2022. The agreement increases the aggregate Revolving Commitment to $2,125,000,000 and extends the Maturity Date for the Revolving Commitment. JPMorgan Chase Bank, N.A. acts as Administrative Agent, with various banks serving as Co-Documentation Agents and Joint Bookrunners.

• ·Amends and restates Existing Credit Agreement dated July 29, 2022
• ·Re-evidences Obligations from the Existing Credit Agreement
• ·Includes provisions for Term Loans, Swingline Loans, and Letters of Credit

23-04-2026

RPM International Inc. announced the appointment of Thomas C. Gentile, III, Chairman, CEO, and President of Hexcel Corporation, to its board of directors effective April 20, 2026, expanding the board to 13 members. Gentile, with prior leadership at Spirit AeroSystems, GE (including GE Capital, GE Healthcare Systems, and GE Aviation Services), McKinsey & Company, CBS, and General Motors, will serve on RPM's compensation committee. RPM Chairman and CEO Frank C. Sullivan highlighted Gentile's expertise in global manufacturing and industrial operations to support long-term growth.

• ·RPM operates across three reportable segments: consumer, construction products, and performance coatings.
• ·Gentile assumed CEO and president role at Hexcel in May 2024 and chairman in December 2024.
• ·Gentile earned bachelor’s degree in economics magna cum laude and MBA from Harvard University; studied international relations at London School of Economics.

23-04-2026

Acadia Healthcare Company, Inc. (ACHC) appointed David Duckworth, former CFO from 2012-2023, as Interim CFO effective May 1, 2026, succeeding Todd Young who departs April 30, 2026, for a CFO role at a private equity-backed animal health company. The company reaffirmed its Q1 2026 guidance of $820-830 million revenue and $130-137 million Adjusted EBITDA, and full-year 2026 guidance of $3.37-3.45 billion revenue and $575-610 million Adjusted EBITDA, with no changes indicating stable outlook amid the leadership transition. As of December 31, 2025, Acadia operates 277 behavioral healthcare facilities with over 12,500 beds, 25,000 employees, and serves more than 84,000 patients daily.

• ·Q1 2026 Adjusted EPS guidance: $0.25 to $0.30
• ·Full-Year 2026 Adjusted EPS guidance: $1.30 to $1.55
• ·Q1 2026 results to be issued after market close on April 29, 2026; earnings call on April 30, 2026 at 9 a.m. EDT
• ·Search for permanent CFO ongoing
• ·Facilities in 40 states and Puerto Rico

23-04-2026

BayCom Corp (NASDAQ: BCML) announced the appointment of Michael J. Perdue as a new director, effective April 22, 2026. Mr. Perdue brings over four decades of community banking leadership, including roles as President of Pacific Western Bank’s San Diego and Desert Regions, President of First Community Bancorp, and CEO/Director of Community Bancorp Inc. (NASDAQ: CMBC), with expertise in growth, acquisitions, and operations in Southern California. Company leadership, including Chairman Lloyd Kendall, Executive Vice Chairman Bill Black, and CEO Christopher Baron, highlighted his value to ongoing strategy execution.

• ·BayCom Corp operates through United Business Bank in California, Washington, New Mexico, and Colorado.
• ·Contact: Kevin L. Thompson, 925-476-1800, klthompson@ubb-us.com

23-04-2026

National Health Investors, Inc. (NHI) announced CFO John Spaid's retirement effective July 1, 2026, with Todd Siefert appointed as Executive Vice President Corporate Finance effective June 1, 2026, to succeed as CFO. Dana Hambly was promoted to Senior Vice President of Finance to support the transition. Leadership highlighted Spaid's contributions to a strong balance sheet and Siefert's 25+ years of REIT experience, positioning the company for continued growth.

• ·NHI established in 1991 as a self-managed REIT focusing on senior housing and medical facilities.
• ·Siefert began career as Senior Consultant at Booz Allen & Hamilton and Merger and Acquisition Analyst at U.S. Department of Justice — Antitrust Division.
• ·Annual Report on Form 10-K referenced for year ended December 31, 2025.

23-04-2026

Green Plains Inc. and subsidiaries entered into a Second Amendment to their Loan and Security Agreement effective April 17, 2026, reducing the Aggregate Revolving Loan Commitment from $350 million to $300 million. However, the Scheduled Termination Date was extended six months from March 25, 2027, to September 25, 2027. Minor updates were made to definitions, sanctions clauses, and lender commitments schedule.

• ·Amendment ratified all existing liens and security interests.
• ·No Default or Event of Default existing post-amendment.
• ·Schedule 1.1 (Revolving Loan Commitments) omitted as confidential.

23-04-2026

Invech Holdings, Inc. entered into an Asset Purchase Agreement on April 18, 2026, with Arpita Day to acquire the website, total code, intellectual property, domains, databases, and other assets of the sports betting platform www.sportypick.com in exchange for 5,000,000 restricted shares of common stock. The transaction closed on April 21, 2026, with the assets transferred to the Company, which created a wholly-owned subsidiary, Sporty Pick, Inc. The shares were issued in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.

• ·APA effective date: April 18, 2026; Closing date: April 21, 2026
• ·Inventory of assets to be taken on April 20, 2026, by Alexander M. Woods-Leo
• ·No liabilities assumed by Buyer; Seller indemnifies Buyer against claims
• ·SEC guidance on monitoring company website (https://invechholdings.com) and X account (https://x.com/invechholdings) for material information

23-04-2026

Lucid Diagnostics Inc. announced the pricing of an underwritten registered direct offering of 18,000,000 common shares at $1.00 per share, anchored by a $15 million investment from a fundamental institutional investor with support from a large existing shareholder. Gross proceeds are expected to be approximately $18 million before deducting underwriting discounts and other expenses, to be used for working capital and general corporate purposes. The offering is expected to close on or about April 24, 2026, subject to customary closing conditions.

• ·Offering pursuant to shelf registration statement on Form S-3 (File No. 333-291981) effective March 26, 2026.
• ·Joint bookrunners: Canaccord Genuity LLC and BTIG, LLC.

23-04-2026

Tectonic Therapeutic, Inc. (NASDAQ: TECX) appointed Jessica Chutter to its Board of Directors, effective June 8, 2026. Ms. Chutter, with over four decades at Morgan Stanley including roles as Vice Chair of Healthcare Investment Banking and Chair of Biotechnology Investment Banking, advised on approximately $80 billion in capital raising and $85 billion in strategic transactions. The appointment aims to bolster strategic positioning as the company advances its two clinical programs targeting three indications and preclinical portfolio.

• ·Filing date: April 23, 2026
• ·Appointment effective date: June 8, 2026
• ·Ms. Chutter's prior roles: Managing Director (1998-February 2026), Vice Chair of Healthcare Investment Banking (2020-February 2026), Chair of Biotechnology Investment Banking (2010-February 2026)
• ·Ms. Chutter serves on boards of PTC Therapeutics, The Hospital for Sick Children, and Toronto Innovation Acceleration Partners
• ·Ms. Chutter holds an M.B.A. from Harvard Business School and a Bachelor of Arts in Commerce and Honors Economics from McGill University

23-04-2026

Ace Green Recycling, Inc. and Athena Technology Acquisition Corp. II announced a $32 million PIPE financing from sector-focused institutional investors to support their proposed business combination, with gross proceeds expected upon closing to fund Ace’s Texas recycling facility development, international operations expansion, and general corporate purposes including potential acquisitions. The combined company anticipates listing on Nasdaq under ticker 'AGXI'. This follows the most recent S-4 registration statement filed on March 24, 2026, marking a key milestone toward transaction completion.

• ·Securities purchase agreements entered for PIPE contingent on business combination closing
• ·S-4 registration statement most recently filed March 24, 2026
• ·Legal counsel: Rimon P.C. for Ace; Latham & Watkins LLP for ATEK II

23-04-2026

Corvus Pharmaceuticals, Inc. appointed Andrew C. Chan, M.D., Ph.D. as a Class II director and to the Nominating Committee, effective April 23, 2026, following a Board recommendation. Simultaneously, Scott Morrison resigned from the Board effective the same date after over a decade of service, including as Audit Committee Chairperson. Dr. Chan will receive a $35,000 annual Board retainer, $4,000 additional for committee service, and an initial stock option for 30,000 shares.

• ·Dr. Chan's Class II director term expires at the 2027 annual meeting of stockholders.
• ·Compensation earned quarterly and prorated for current quarter; eligible for subsequent equity awards.
• ·References Company's non-employee director compensation program (Exhibit 10.10 to 10-K filed March 12, 2026) and standard indemnification agreement (Exhibit 10.4 to same 10-K).

23-04-2026

On April 21, 2026, the Compensation Committee of Twin Vee PowerCats Co. approved an increase in the annual base salary of Vice President Preston Yarborough to $250,000. On April 22, 2026, the company entered into an amendment to his employment agreement, effective as of the original July 23, 2021 agreement, reflecting the salary increase and terminating a prior amendment dated June 27, 2024. The amendment is filed as Exhibit 10.1.

• ·The company is an emerging growth company under Rule 405 and Rule 12b-2.
• ·Securities registered: Common stock, par value $0.001 per share, trading symbol VEEE on Nasdaq Capital Market.